Mobi-C Cervical Disc
The leading choice for cervical motion preservation
Mobi-C Cervical Disc was the first cervical disc in the United States approved to treat more than one level of the cervical spine. Mobi-C was determined by the FDA to be statistically superior to fusion at 7 years for two-level cervical disc replacement, based on the primary study endpoint of a prospective, concurrently controlled and randomized, multi-center clinical trial.
At 10 years, all patient-reported outcomes were equivalent to or improved from 7 years.
Mobi-C 경추 디스크는 미국에서 경추의 1 level 이상을 치료하도록 승인된 FDA 최초의 경추 디스크입니다.
FDA는 Mobi-C가 2 level 경추 디스크 치환술에 있어서 통계적으로 7년차 유합술보다 우수한 것으로 인정하였습니다.
Mobi-C 경추 디스크 치환술 후 10년이 경과된 모든 환자들의 수술 예후가 7년차때의 경과와 같거나 보다 더 향상되었습니다.
Mobi-C Keynotes
Brochure & Surgical Technique
Mobi-C Brouchure
Mobi-C Surgical Technique
Clinical Summaries